|
BMS1P4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.340230E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.485800E-01 |
| Normal-vs-Stage2 |
3.160600E-01 |
| Normal-vs-Stage3 |
7.231000E-01 |
| Normal-vs-Stage4 |
6.702400E-01 |
| Stage1-vs-Stage2 |
6.268400E-01 |
| Stage1-vs-Stage3 |
2.216200E-01 |
| Stage1-vs-Stage4 |
8.591000E-01 |
| Stage2-vs-Stage3 |
2.310600E-01 |
| Stage2-vs-Stage4 |
6.853000E-01 |
| Stage3-vs-Stage4 |
5.348600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.602220E-01 |
| Normal-vs-AfricanAmerican |
1.946560E-01 |
| Normal-vs-Asian |
7.209000E-01 |
| Caucasian-vs-AfricanAmerican |
7.815600E-01 |
| Caucasian-vs-Asian |
4.467600E-01 |
| AfricanAmerican-vs-Asian |
4.380600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.950960E-01 |
| Normal-vs-Female |
1.066150E-01 |
| Male-vs-Female |
4.945800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.740400E-01 |
| Normal-vs-Extreme_Weight |
7.004200E-01 |
| Normal-vs-Obese |
1.396600E-01 |
| Normal-vs-Extreme_Obese |
5.501200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.488400E-01 |
| Normal_Weight-vs-Obese |
3.420800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.220000E-01 |
| Extreme_Weight-vs-Obese |
2.365400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.894800E-01 |
| Obese-vs-Extreme_Obese |
7.305400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.801600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.550200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.556800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.080630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.962200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.242600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.826300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.151000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.980180E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.260300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.614400E-02 |
| Normal-VS-Type2 PRCC |
1.480230E-01 |
| Normal-VS-KIRP CIMP |
7.814800E-01 |
| Normal-VS-Unclassified PRCC |
7.732300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.05689999996272E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.164800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.304600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.363800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.501000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.053000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.520400E-01 |
| Normal-vs-N1 |
8.329400E-01 |
| Normal-vs-N2 |
5.892800E-01 |
| N0-vs-N1 |
6.157400E-01 |
| N0-vs-N2 |
6.772800E-01 |
| N1-vs-N2 |
5.996200E-01 |
|
|
